Results 141 to 150 of about 33,006 (235)

IGFBP1 as a metabolic-neurodegenerative biomarker in spinocerebellar ataxia type 3. [PDF]

open access: yesExp Ther Med
Chiu C   +8 more
europepmc   +1 more source

Content Validity of the Spinocerebellar Ataxia Composite Score as a Measure of Disease Progression in Patients with Spinocerebellar Ataxia. [PDF]

open access: yesCerebellum
Potashman M   +14 more
europepmc   +1 more source

Predictive models for ataxia progression and conversion in spinocerebellar ataxia type 1 and 3. [PDF]

open access: yesBrain
Petit E   +29 more
europepmc   +1 more source

Physiotherapy in Spinocerebellar Ataxia Following COVID-19: A Biomechanical and Biopsychosocial Case Report. [PDF]

open access: yesPhysiother Res Int
Monteiro LHF   +5 more
europepmc   +1 more source

Oligodendrocyte dysfunction contributes to motor deficits and Purkinje cell axonopathy in spinocerebellar ataxia type 1. [PDF]

open access: yesJ Clin Invest
Lee C   +9 more
europepmc   +1 more source

Clinical Characteristics of Patients with Spinocerebellar Ataxia 7

open access: yes, 2009
Spinocerebellar ataxia type 7 (SCA7) is a rare autosomal dominantly inherited neurodegenerative disorder. It is due to abnormal CAG trinucleotide repeat expansion. SCA7 is the only inherited ataxia invariably associated with a cone-rod dystrophy.
Randee Miller; Gregory Van Stavern
core  

An intronic variant in Ferredoxin Reductase (FDXR) creates a cryptic exon in Quarter Horses with Equine Juvenile Spinocerebellar Ataxia. [PDF]

open access: yesPLoS Genet
Brown BN   +13 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy